Cargando…
Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53
Oxaliplatin resistance is a major issue in the treatment of p53 mutant colorectal cancer (CRC). Finding the specific biomarkers would improve therapeutic efficacy of patients with CRC. In order to figure out the biomarker for CRC patients with mutant p53 access oxaliplatin, a Gene Expression Omnibus...
Autores principales: | Wang, Wei-Lin, Batzorig, Uyanga, Hung, Chin-Sheng, Wei, Po-Li, Huang, Chien-Yu, Chang, Yu-Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844434/ https://www.ncbi.nlm.nih.gov/pubmed/35178443 http://dx.doi.org/10.1155/2022/1322788 |
Ejemplares similares
-
The roles of aldehyde dehydrogenases (ALDHs) in the PDH bypass of Arabidopsis
por: Wei, Yanling, et al.
Publicado: (2009) -
Update on the aldehyde dehydrogenase gene (ALDH) superfamily
por: Jackson, Brian, et al.
Publicado: (2011) -
Aldehydes, Aldehyde Metabolism, and the ALDH2 Consortium
por: Rwere, Freeborn, et al.
Publicado: (2022) -
The Aldehyde Dehydrogenase ALDH2*2 Allele, Associated with Alcohol Drinking Behavior, Dates Back to Prehistoric Times
por: Lin, Chih-Lang, et al.
Publicado: (2021) -
Aldehyde Dehydrogenase 2 (ALDH2) in Rat Fatty Liver Cold Ischemia Injury
por: Panisello-Roselló, Arnau, et al.
Publicado: (2018)